These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10668704)

  • 21. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults.
    Bondi MW; Salmon DP; Monsch AU; Galasko D; Butters N; Klauber MR; Thal LJ; Saitoh T
    Neurology; 1995 Dec; 45(12):2203-6. PubMed ID: 8848194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.
    Lavretsky H; Ercoli L; Siddarth P; Bookheimer S; Miller K; Small G
    Am J Geriatr Psychiatry; 2003; 11(6):667-73. PubMed ID: 14609807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-epsilon4.
    Olofsson JK; Rönnlund M; Nordin S; Nyberg L; Nilsson LG; Larsson M
    Behav Genet; 2009 Sep; 39(5):496-503. PubMed ID: 19633944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.
    Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L
    JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function.
    Carmelli D; DeCarli C; Swan GE; Kelly-Hayes M; Wolf PA; Reed T; Guralnik JM
    J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):M103-9. PubMed ID: 10737693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E, cognitive function, and dementia in a general population aged 85 years and over.
    Juva K; Verkkoniemi A; Viramo P; Polvikoski T; Kainulainen K; Kontula K; Sulkava R
    Int Psychogeriatr; 2000 Sep; 12(3):379-87. PubMed ID: 11081958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
    Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study.
    Corrada MM; Paganini-Hill A; Berlau DJ; Kawas CH
    Alzheimers Dement; 2013 Jan; 9(1):12-8. PubMed ID: 23123227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women.
    Yaffe K; Cauley J; Sands L; Browner W
    Arch Neurol; 1997 Sep; 54(9):1110-4. PubMed ID: 9311354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease.
    Traykov L; Rigaud AS; Baudic S; Smagghe A; Boller F; Forette F
    J Neurol Sci; 2002 Nov; 203-204():177-81. PubMed ID: 12417380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The apolipoprotein E epsilon 2 allele and decline in episodic memory.
    Wilson RS; Bienias JL; Berry-Kravis E; Evans DA; Bennett DA
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):672-7. PubMed ID: 12438469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.
    van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH
    Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers.
    Dufouil C; Tzourio C; Brayne C; Berr C; Amouyel P; Alpérovitch A
    Epidemiology; 2000 May; 11(3):280-4. PubMed ID: 10784244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition.
    Corder EH; Lannfelt L; Viitanen M; Corder LS; Manton KG; Winblad B; Basun H
    Arch Neurol; 1996 May; 53(5):418-22. PubMed ID: 8624216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein epsilon4 allele and problems with orientation are associated with a persistent decline in cognition in community-dwelling elderly persons.
    Wayne SJ; Vellas BJ; Brodie SG; Garry PJ; Baumgartner RN
    J Gerontol A Biol Sci Med Sci; 2005 Mar; 60(3):375-9. PubMed ID: 15860477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.
    Payami H; Grimslid H; Oken B; Camicioli R; Sexton G; Dame A; Howieson D; Kaye J
    Am J Hum Genet; 1997 Apr; 60(4):948-56. PubMed ID: 9106542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
    Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
    Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.